What was U-Neuron Biomedical Inc’s price range in the past 12 months?
U-Neuron Biomedical Inc lowest stock price was TWD 31.30 and its highest was TWD 70.20 in the past 12 months.
What is U-Neuron Biomedical Inc’s market cap?
U-Neuron Biomedical Inc’s market cap is TWD 2.16B.
When is U-Neuron Biomedical Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is U-Neuron Biomedical Inc overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does U-Neuron Biomedical Inc pay dividends?
U-Neuron Biomedical Inc does not currently pay dividends.
What is U-Neuron Biomedical Inc’s EPS estimate?
U-Neuron Biomedical Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does U-Neuron Biomedical Inc have?
U-Neuron Biomedical Inc has 40,803,000 shares outstanding.
Which hedge fund is a major shareholder of U-Neuron Biomedical Inc?
Currently, no hedge funds are holding shares in TW:6973
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
U-Neuron Biomedical Inc
U-Neuron Biomedical Inc. specializes in the pioneering development of stem cell technologies. The company's core activities revolve around advancing methods for stem cell preservation, isolation, and their subsequent application in therapeutic treatments. Their research specifically targets Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. This enterprise was established on September 4, 2015, and is based in New Taipei, Taiwan.